ArticleCell biochemistry and biophysics2026
Role of MIR-101-3P/RAP1B Axis and Insulin Protection in Glucose-Induced Stress in HK-2 Cell Model for Diabetic Kidney Disease.
Article in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Proximal tubular cell (PTC) injury is a critical driver of diabetic kidney disease (DKD). This study aimed to characterize the molecular response of HK-2 PTCs to acute glucotoxicity, focusing on the miR-101-3p/RAP1B axis, insulin-mediated protection, and the primary mechanisms of cell death. HK-2 cells were exposed to varying glucose concentrations (5.5–128 mM) with or without insulin (10 mg/L) for 48 h. We assessed cell viability, mitochondrial membrane potential (ΔΨm), and intracellular reactive oxygen species (ROS). Expression of miR-101-3p, RAP1B, insulin receptor substrates (IRS1/2), and apoptotic proteins (BCL-2, Cytochrome c) was quantified by qPCR and Western blotting. High glucose induced dose-dependent cell death, which was potently rescued by insulin, particularly at 25 mM glucose (viability restored from 76% to 98%, p < 0.0001). This protection strongly correlated with significant RAP1B protein upregulation (p < 0.05), while miR-101-3p expression remained stable. Mechanistically, severe hyperglycemia (128 mM) caused a profound collapse in ΔΨm (p < 0.01) and increased Cytochrome c levels, without a corresponding rise in ROS. Furthermore, severe hyperglycemia suppressed IRS1 expression, potentially limiting insulin’s protective capacity. Acute PTC injury from glucotoxicity is primarily driven by mitochondrial dysfunction and intrinsic apoptosis, rather than by classic oxidative stress. The strong association between insulin mediated survival and RAP1B upregulation suggests the RAP1B signalling pathway as a key component of the PTC defence against hyperglycaemic stress. This work provides a refined model of PTC injury and highlights the RAP1B axis as a promising potential therapeutic target in DKD.
Indexed as
Identifiers
41511496What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.